8-K
filed January 16, 2025, 6:59 PM ET
CIK 0001785592
other material
confidence high
sentiment negative
materiality 0.90
Leafly receives Nasdaq delisting notice; stock to move to OTC Pink; convertible notes extended to July 2025
Leafly Holdings, Inc. /DE
- Nasdaq Hearings Panel determined to delist Leafly common stock and warrants; trading suspended Jan 17, 2025.
- Stock and warrants expected to trade on OTC Pink Open Market under symbols LFLY and LFLYW.
- Maturity of 8.00% convertible senior notes extended from Jan 31, 2025 to July 1, 2025.
- Company to prepay 12.5% of outstanding principal plus accrued interest on Jan 21, 2025; added covenants and security interest.
- Delisting due to failure to meet Nasdaq's net income continued listing standard; alternative compliance not achieved.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0000950170-25-006032
- form_type
- 8-K
- ticker
- null
- cik
- 0001785592
- company_name
- Leafly Holdings, Inc. /DE
- filed_at
- 2025-01-16T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:04.852313+00:00
- generated_at
- 2026-05-28T00:11:59.022707+00:00
- sec_items
- ["1.01", "3.01", "3.03", "7.01", "9.01"]
- event_type
- other_material
- sentiment
- negative
- materiality_score
- 0.9
- calibrated_materiality_score
- 0.9
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0000950170-25-006032
- json_url
- https://secwatch.observer/filing/0000950170-25-006032.json
- markdown_url
- https://secwatch.observer/filing/0000950170-25-006032.md
- text_url
- https://secwatch.observer/filing/0000950170-25-006032.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1785592/000095017025006032/0000950170-25-006032-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1785592/000095017025006032/lfly-20250115.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
DRCT
DRCT enters $50M equity line with Roth, terminates New Circle ELOC, receives Nasdaq delisting notice
Direct Digital Holdings, Inc.
April 28, 2026, 7:59 PM ET
other_material
Items 1.01, 1.02, 3.01, 3.03, 5.03, 9.01
same fact type: exchange_compliance_notice
same SEC item: 1.01, 3.01, 3.03, 9.01
same event type: other_material
similar materiality
This filing
January 15, 2025, the Company received written notification (the “Delisting Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s common
Comparable filing
April 23, 2026, the Company received an Additional Staff Delisting Determination Letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Company that it is not in comp
Filing page
SEC filing
PMI
Picard Medical Q1 revenue up 85% to $1.2M; reports $1.4M negative equity, NYSE listing notices
Picard Medical, Inc.
May 21, 2026, 4:15 PM ET
other_material
Items 2.02, 3.01, 7.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 7.01, 9.01
same event type: other_material
similar materiality
This filing
January 15, 2025, the Company received written notification (the “Delisting Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s common
Comparable filing
reviously disclosed, on May
8, 2026, the Company received a notice that it was not in compliance with Section 1003(a)(ii) (the “May 8 Notice,” and together
with the May 15 Notice, the “ Notices ”). In connection with the
Filing page
SEC filing
BKYI
BIO-key receives Nasdaq delisting notice; stock to move to OTC Markets on May 13
BIO KEY INTERNATIONAL INC
May 12, 2026, 4:46 PM ET
other_material
Items 3.01, 7.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 7.01, 9.01
same event type: other_material
similar materiality
This filing
January 15, 2025, the Company received written notification (the “Delisting Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s common
Comparable filing
May 6, 2026, BIO-key International, Inc. (the “ Company ”) received notice from the staff of The Nasdaq Stock Market, LLC (“ Nasdaq ”) stating that the Company had not regained compliance with Nasdaq Listing Rule 5550(a)
Filing page
SEC filing
PMI
Picard Medical raises $5M in public offering, receives NYSE American delisting notice for low equity
Picard Medical, Inc.
May 11, 2026, 5:08 PM ET
other_material
Items 1.01, 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 1.01, 3.01, 9.01
same event type: other_material
similar materiality
This filing
January 15, 2025, the Company received written notification (the “Delisting Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s common
Comparable filing
May 8, 2026, the Company received a written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”) requiring a company to have stockholders’ equity of at least $4.0 million if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. The Notice states that the Company reported a stockholders’ equity of approximately $3.8 million as of
Filing page
SEC filing
ADTX
Aditxt receives Nasdaq deficiency for negative equity; delisting hearing set for June 11
Aditxt, Inc.
May 29, 2026, 4:21 PM ET
other_material
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
same event type: other_material
similar materiality
This filing
January 15, 2025, the Company received written notification (the “Delisting Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s common
Comparable filing
May 27, 2026, Aditxt, Inc. (the “Company”)
received a letter (the “Letter”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market
LLC (“Nasdaq”) notifying the Company that, based on the stockholders’ equity of $(35,174,386) reported in the Company’s
Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”), the Company no longer satisfies the minimum
stockholders’ equity requirement of $2,500,000 for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1)
(the “Stockholders’ Equity Requirement”). The Letter further
Filing page
SEC filing
LIMN
Liminatus Pharma receives Nasdaq delisting notice; appeals filed
Liminatus Pharma, Inc.
May 27, 2026, 4:30 PM ET
other_material
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
same event type: other_material
similar materiality
This filing
January 15, 2025, the Company received written notification (the “Delisting Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s common
Comparable filing
May 20, 2026, the Company received a notice
from Nasdaq stating that the Company had not regained compliance with the MVLS Rule and the MVPHS Rule. Accordingly, its securities will
be delisted from The Nasdaq Global Mark
Filing page
SEC filing
XXI
Tether International acquires SoftBank's stake in Twenty One Capital; board members resign
Twenty One Capital, Inc.
May 20, 2026, 8:49 AM ET
other_material
Items 1.02, 3.01, 5.02, 8.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
same event type: other_material
similar materiality
This filing
January 15, 2025, the Company received written notification (the “Delisting Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s common
Comparable filing
o independent directors, the minimum number required during the transition period
for compliance with Section 303A.07(a) of the NYSE Listed Company Manual, as provided in Section 303A.00 of the NYSE Listed Company Manual
Filing page
SEC filing
GCTK
Glucotrack receives second Nasdaq delisting notice; plans to appeal by May 18
Glucotrack, Inc.
May 15, 2026, 4:45 PM ET
other_material
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
same event type: other_material
similar materiality
This filing
January 15, 2025, the Company received written notification (the “Delisting Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s common
Comparable filing
May 15, 2026, the Company received a second letter from Nasdaq notifying the Company that its Form 10-Q for the period ended March
31, 2026, indicates that the Company no longer meets the $2,500,000 minimum stockholders’
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.